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Abstract
Helios, an Ikaros family transcription factor, is preferentially expressed at the mRNA and protein level in regulatory T cells.
Helios expression previously appeared to be restricted to thymic-derived Treg. Consistent with recent data, we show here
that Helios expression is inducible in vitro under certain conditions. To understand phenotypic and functional differences
between Helios
+ and Helios
2 Treg, we profiled cell-surface markers of FoxP3
+ Treg using unmanipulated splenocytes. We
found that CD103 and GITR are expressed at high levels on a subset of Helios
+ Treg and that a Helios
+ Treg population
could be significantly enriched by FACS sorting using these two markers. Quantitative real-time PCR (qPCR) analysis
revealed increased TGF-b message in Helios
+ Treg, consistent with the possibility that this population possesses enhanced
regulatory potential. In tumor-bearing mice, we found that Helios
+ Treg were relatively over-represented in the tumor-mass,
and BrdU studies showed that, in vivo, Helios
+ Treg proliferated more than Helios
2 Treg. We hypothesized that Helios-
enriched Treg might exert increased suppressive effects. Using in vitro suppression assays, we show that Treg function
correlates with the absolute number of Helios
+ cells in culture. Taken together, these data show that Helios
+ Treg represent
a functional subset with associated CD103 and GITR expression.
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Introduction
Regulatory T cells (Treg) are a CD4 subset that suppresses the
function of multiple types of hematopoetic effector cells. This
functionality most likely evolved to prevent the development of
autoimmunity as a consequence of over-exuberant immune
activation [1–5]. Correspondingly, Treg down-regulate immunity
to certain pathogens [6], a property that appears to have been
hijacked by tumors [5–7] in their efforts to escape immune
surveillance. In general, Treg are characterized by the expression
of the FoxP3 transcription factor [8], although some studies
indicate that functional Treg can develop in the absence of Foxp3
[9]. One broad classification of Treg is based on the notion that
some FoxP3 positive cells appear to be thymic-derived (natural
Treg or nTreg), while other FoxP3 positive cells are induced
peripherally (induced Treg or iTreg) [10].
Several microarray studies [11–13], including our own [14],
showed a relative upregulation of the Ikaros family transcription
factor Helios in Treg. In addition, two recent studies suggested
that Helios expression might distinguish thymic-derived from
induced Treg [15,16]. However, this notion was recently
challenged by a clear demonstration of Helios expression induced
in transgenic CD4 T cells upon recognition of their cognate
antigen in the presence of IL-2 and TGF-b [17]. These data
suggest that the method of activation could determine Helios
expression in iTreg, a finding so far unexplored in a non-TCR
transgenic CD4
+ T cell population.
A functional role for Helios in either natural or induced Treg
remains unclear. Previous studies by our group have demonstrated
that Helios binds to the FoxP3 promoter and upregulates FoxP3
expression [16]. Homozygous deletion of Helios was neonatally
lethal in C57/Bl6 mice; the etiology for that early death remains
unexplained. However, on a mixed background (129/Sv:B6),
knocking out Helios did not appear to affect the absolute number
of Treg or interfere with their function [18]. Using a targeted
approach, Thorton et al. deleted Helios in CD4 cells by crossing
CD4-Cre mice to Helios-fl/fl animals [15]. Consistent with the
results from the genomic knockout studies, no defect in Helios-
deficient Treg function was noted. Forced over-expression of Helios
in Treg has not been well-described; indeed, we found that
transduction of naı ¨ve human CD4 cells with a Helios expression
construct appeared to induce apoptosis [16]. Based on these data,
we sought to understand Helios function in Treg using an
alternative approach. First we surveyed Helios
+ versus Helios
2
Treg for a set of cell surface markers that could enrich for Helios
+
cells. Next, we used FACS sorting to enrich for a Helios
+ population
of Treg among naturally occurring FoxP3
+ splenocytes, and
quantified their phenotypic and functional characteristics.
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Animals
BALB/cJ mice were purchased from The Jackson Laboratory
(Bar Harbor, ME). FoxP3-GFP knock-in mice on C57BL/6
background were a generous gift of Dr. S Rudensky (Memorial
Sloan Kettering Cancer Center, New York, NY). Mice were
studied at 4–8 weeks of age. All animal studies were performed in
accordance with protocols approved by the Animal Care and Use
Committee of the Johns Hopkins University School of Medicine
(animal protocol numbers MO10M44 and M009M100).
In vitro Treg induction
Spleens and axillary lymph nodes were harvested from BALB/
cJ or FoxP3-GFP mice and enriched for CD4
+ cells via magnetic
bead separation according to the manufacturer’s protocol
(Miltenyi Biotec, Auburn, CA). Naı ¨ve CD4 T cells
(CD4
+CD25
2CD62L
hi) were obtained by FACS sorting using a
FACSAria II (BD, Franklin Lakes, NJ). Cells were skewed toward
a Treg phenotype by activation with immobilized aCD3e (clone
145-2c11) (5 mg/mL) and soluble aCD28 (clone 37.51) (1 mg/mL)
in the presence of rTGF-b (2.5 ng/mL) and rIL2 (40 ng/mL) in
RPMI as previously described or by CD3/CD28 T-activator
beads (Invitrogen Dynal, Oslo), in the presence of rTGF-b
(2.5 ng/mL) and rIL2 (40 ng/mL) in RPMI [14]. Stimulation by
CD3/CD28 microbeads was performed in the absence of APCs.
Flow cytometry and extracellular (ECS) and intracellular
staining (ICS)
Fluorescent conjugated monoclonal antibodies were purchased
from BD or eBioscience (San Diego, CA) with the exception of
aHelios-FITC and aHelios-AF647 which were obtained from
Biolegend (San Diego, CA). Gates and quadrants were set based
on isotype control staining. MFI values were obtained using
FlowJo software (Treestar, Ashland, OR) and are reported as
relative MFI values using naı ¨ve CD4 T cells (CD4
+ CD25
2
FoxP3
2 CD62L
hi) as a comparison.
Treg subset sorting
Spleens and axillary LNs were pooled from BALB/cJ mice and
enriched for CD4
+ T cells by negative selection using the mouse
CD4
+ T Cell Isolation Kit II (Miltenyi Biotec). CD4
+ CD25
+ cells
were sorted based upon GITR and CD103 expression using the
FACSAria II cell sorter (BD). Intracellular staining for FoxP3 and
Helios was performed on the Treg populations obtained after
sorting as per the manufacturer’s protocol (eBioscience). After
sorting, cells were analyzed for sorting purity and FoxP3 and
Helios expression using an LSRII (BD) and FACSDiva software
(BD).
Quantitative real-time PCR
Total RNA was extracted using the RNeasy Micro Kit (Qiagen,
Venlo, Netherlands) and cDNA was synthesized with the SMART
PCR cDNA synthesis kit (Clontech, Mountain View, CA). All
primers were purchased from Applied Biosystems (Carlsbad, CA);
reactions were performed in duplicate in 2 independent experiments
using an Applied Biosystems 7500 instrument. Relative mRNA
frequencies were calculated in relation to 16 s mRNA expression as
follows: 2
DDCt where DDCt=(DCtc a l i b r a t i o n 2DCts a m p l e ).
In vitro suppression assay
These assays were performed as previously described [19].
Briefly, spleens and axillary lymph nodes from BALB/cJ mice
were pooled and enriched for CD4
+ T cells by negative selection
(Miltenyi Biotec). The CD4
2 splenocyte fraction was collected and
irradiated with 3000 rads to be used as accessory cells. The CD4
+
T cell fraction was sorted for CD4
+ CD25
2 effector T cells, as well
as CD4
+CD25
+GITR
+CD103
2 Tregs, CD4
+ CD25
+ GITR
low
CD103
2 Treg, and CD4
+ CD25
+ GITR
+ CD103
+ (Helios-
enriched) Treg and bulk CD4
+CD25
+ Tregs. 2.5610
4 effector T
cells were co-cultured with or without suppressors in various ratios
in cytotoxic lymphocyte (CTL) media [14], along with 2.5610
4
accessory cells and were stimulated for three days with soluble
aCD3 (1 mg/ml). On day three, cells were resuspended in media
containing 1 mg/mL tridiated thymidine for 16 hours. H
3
incorporation was quantified using a MicroBeta Plate Harvester
and Reader (Perkin Elmer, Waltham, MA).
Experimental tumors and in vivo BrdU labeling of Treg
BALB/cJ mice were injected subcutaneously with 2610
6 4T1
tumor cells (American Type Culture Collection, Manassas VA).
On days 8 and 9 post tumor injection, animals were injected IP
with 2 mg of BrdU solution (BD). 24 hours after the second BrdU
injection, mice were sacrificed and their spleens, axillary lymph
nodes, tumor draining inguinal lymph nodes, and tumor
infiltrating lymphocytes were isolated and stained for flow
cytometric analysis. Extracellular staining was performed as
previously described and cells were then incubated in Fix-Perm
buffer (eBiosciences) for 16 hours. Cells were washed in Perm
Buffer (eBiosciences) and were then DNAse (BD) treated for
1 hour at 37uC, washed in Perm Buffer and stained intracellularly
for FoxP3, Helios, and BrdU.
Statistical Analysis
Statistical analysis was performed using Prism 5 (GraphPad, La
Jolla, CA). Unpaired two-tailed t-tests were conducted and
considered significant at p-values#0.05 (*), 0.01 (**) and 0.001
(***).
Results
Helios upregulation in in vitro induced Treg
Based on recent data [17], we hypothesized that Helios
expression could be induced in Treg derived from a naı ¨ve, bulk
CD4 population in vitro. To test this hypothesis, naı ¨ve CD4 T cells
were obtained from wildtype mice using CD62L as a marker for
the naı ¨ve population. As shown in Figure 1A, less than 1% of these
naı ¨ve T cells were positive for both FoxP3 and Helios. After
48 hours of stimulation in the presence of TGF-b and IL-2,
approximately 87% of the CD4 cells expressed FoxP3. A FoxP3
+
Helios
+ population was clearly observed, representing 33% of total
cells. Identical results were obtained using CD45RB as a marker
for naı ¨ve cells (data not shown). We extended these results using
FoxP3-GFP reporter mice [11] (Figure 1B), here sorting for naı ¨ve
(CD62L
hi) GFP
2 cells. These data confirmed the observation that
Helios expression indeed depends on the TCR signal provided:
immobilized aCD3/soluble aCD28 induced significant FoxP3,
but did not induce appreciable Helios, consistent with previous
studies [15,16]. Significantly, increasing either immobilized aCD3
or soluble aCD28 signaling was not sufficient to induce
appreciable Helios expression (Figure S1). However, when TCR
signaling was provided with aCD3/aCD28 microbeads in the
absence of APCs, a significant percentage of cultured cells once
again co-expressed both FoxP3 and Helios. Taken together these
data are support a model in which Helios expression is not
exclusive to natural Treg, and show that Helios expression can be
induced in vitro under certain stimulation conditions.
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We next set out to determine the relative cell surface phenotype
of Helios
+ versus Helios
2 Treg. CD4
+ splenocytes obtained from
wildtype BALB/c mice, and FoxP3
+ CD4 cells were gated on the
Helios
+ versus Helios
2 FoxP3
+ populations (Figure 2A). We also
determined the relative cell surface phenotype of in vitro induced
Helios
+ versus Helios
2 Treg (Figure 2D). As expected, all four
populations of Treg showed a relative increase in CD25 expression
as compared to FoxP3
2 CD4 T cells (show in in green in Figure 2B
and Figure 2D). There was no significant difference in the
expression of either CCR7 or CD127 between Helios
+ and
Figure 1. Helios up-regulation in induced Treg is determined by TCR signal. A) Wildtype mice: Naı ¨ve CD4
+ T cells were purfied by sorting,
and stimulated in vitro in the presence of TGF-b and aCD3/aCD28 microbeads. 48 hours post stimulation, Helios and FoxP3 expression was assayed
by intracellular staining. Data shown are representative of 2 independent experiments, n=5. B) FoxP3-GFP mice: Naı ¨ve, GFP
2 cells were obtained by
sorting and stimulated in vitro with either monoclonal antibodies or aCD3/aCD28 beads. As above, Helios and FoxP3 expression was assayed after
48 hours. Data shown are representative of 2 independent experiments, n=5.
doi:10.1371/journal.pone.0034547.g001
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2 Treg. Direct ex vivo, Helios
+ Treg expressed LFA-1 to a
significantly greater extent than Helios
2 Treg; but the in vitro
induced Treg showed the opposite expression pattern. Interest-
ingly, a subset of the direct ex vivo Helios
+ Treg exhibited a
significantly higher level of expression of both GITR and CD103
as compared to their Helios
2 counterparts. This trend was also
observed for the in vitro induced Treg, but was not as pronounced.
We further examined these differences in expression levels by
comparing the relative MFI for each population, using the MFI of
FoxP3
2 CD4 T cells as a control (Figure 2C and 2E), finding that
the MFI of GITR and CD103 was increased on Helios
+ as
opposed to Helios
2 Treg. Taken together, these data suggest that
sorting ex vivo CD4
+ T cells on GITR and CD103 (in addition to
CD4 and CD25) could potentially enrich a Helios
+ FoxP3
+ Treg
population for further study. It should be noted that the relative
over-expression GITR and CD103 on Helios+ versus Helios- Treg
was also observed on the induced Treg as well, but those
differences were small in magnitude; thus we focused our future
studies on the direct ex vivo Treg populations.
Helios is relatively enriched in a sorted CD103
+ GITR
+
Treg population
We used this difference in the expression of GITR and CD103 to
enrich for Helios
+ Treg by FACS sorting using only extracellular
markers. The sorting strategy, shown in Figure 3A, was to gate on
CD4
+ CD25
+ and then sort these cells into distinct populations
based on CD103 and GITR expression. By sorting CD4
+ CD25
+
cells into a CD103
+ GITR
+ population, we were able to enrich for
Helios
+Treg cellsbyapproximately 2.5foldcomparedto sorting for
the CD4+ CD25+ CD103
2 GITR
low population and by approx-
imately 1.5 fold compared to the bulk CD4
+CD25
+ population.
Interestingly, sorting CD4
+ CD25
+ cells on GITR alone provided a
modest enrichment for Helios expression compared to sorting on
CD4 and CD25, but not as much as by sorting on both GITR and
CD103. We next explored differences in the expression of several
Treg associated transcripts, at the mRNA level, in the populations
obtained through sorting, comparing mRNA expression levels in
the post-sort Treg populations using qPCR. For these studies,
relative mRNA expression was compared to that in naı ¨ve CD4
+ T
cells (Figure 3B). The increased level of expression of Helios seen at
the protein level in the CD103
+ GITR
+ populationcomparedto the
CD103
2 GITR
low population was also observed at the mRNA
level: Helios mRNA expression was tenfold higher in Helios
+
enriched CD103
+ GITR
+ Treg compared to CD103
2 GITR
low
Treg. We found a decreased expression of FoxP3 mRNA in the
CD103
2 GITR
low population, which supports the finding that the
CD4
+ CD25
+ CD103
2 GITR
low population shows slightly
decreased levels of FoxP3 protein expression by FACS analysis
(Figure 3A). Interestingly, the Helios
+ enriched CD103
+ GITR
+
population showed relatively increased expression of LAG-3, which
has been suggested to be a marker of functional Treg [20,21] at the
mRNA level, but cell-surface protein levels of LAG-3 were not
significantly different between Helios
+ and Helios
2 Treg (data not
shown). Increased levels of IL-2 might reflect that Helios+ Treg
represent a set of actively dividing population of Treg. In addition,
we found that the CD103
+ GITR
+ population had a tenfold
increase in TGF-b mRNA expression compared to CD103
2
GITR
low Treg. This relative up-regulation of TGF-b message
appeared to be associated with CD103, as opposed to GITR
expression, as it was not noted in the CD103
2 GITR
+ population.
Taken together, these data led us to hypothesize that Helios
+ Treg
might exhibit more suppressive function in vitro than Helios
2 Treg.
Proliferating Helios
+ Treg are a major population in
tumors
Given the well-documented role of Treg in attenuating an anti-
tumor immune response [5,7], we next examined the number and
relative proliferation of Helios
+ versus Helios
2 Treg in tumor-
bearing mice. To perform these studies, wildtype BALB/c mice
were inoculated with 4T1 mammary tumors, and harvested 10
days after implantation. Interestingly, CD4
+ FoxP3
+ Helios
+ Treg
appeared to be relatively enriched in the tumor parenchyma as
compared to corresponding spleens (Figure 4A). Quantitative
analyses verified these observations by supporting the concept that
Helios
+ Treg are significantly more prevalent in the tumor
parenchyma than are Helios
2 Treg (Figure 4B). In non-tumor
bearing mice, the ratio of Helios
+ to Helios
2 Treg in the spleen
and axillary lymph nodes was approximately the same as in tumor-
bearing mice (data not shown). More significantly, the Helios
+
Treg in the tumor showed a greater extent of BrdU incorporation
than Helios
2 Treg in the same site (Figure 4C). This observation
was not limited to the spleen; in all tissues examined Helios
+ Treg
showed greater BrdU incorporation than their Helios
2 counter-
parts (Figure 4D). Interestingly, we further found that in Treg from
tumors CD103 no longer distinguished between Helios
2 and
Helios
+ Treg (data not shown), a finding consistent with recently
published data [22], but which compromised our ability to
perform functional analyses of Helios
+ versus Helios
2 Treg
derived from the tumor-infiltrating population. In total, these
data show that the predominant FoxP3
+ population found within
tumor parenchyma expresses Helios and proliferates more
robustly in comparison to their Helios
2 counterparts.
Correlation of in vitro Treg suppressive function with
Helios expression
Based on the finding that TGF-b is relatively over-expressed at
the message level in Helios enriched (CD103
+ GITR
+) Treg, we
hypothesized that these Helios-enriched Treg might demonstrate a
Figure 2. Helios
+ and Helios
2 FoxP3
+ Treg cells differ in their cell surface protein expression of CD103 and GITR. A) Gating strategy:
Unstimulated, CD4
+ FoxP3
+ cells were obtained from BALB/cJ splenocytes, stained and gated on the Helios
+ and Helios
2 populations. B) Direct ex
vivo Treg: Top row: Expression of indicated cell surface molecules on CD4
+ FoxP3
+ Helios
+ Treg (blue) overlaid with expression on naı ¨ve CD4 T cells
(green). Bottom row: Expression on CD4
+ FoxP3
+ Helios
2 Treg (red), overlaid with expression on naı ¨ve CD4
+ cells. Percentages indicate the
percentage of Treg that are positive for expression of the surface marker compared to naı ¨ve control cells. C) Mean Fluorescence Intensity (MFI) values
for each cell surface protein in the Helios
+ (blue) and Helios
2 (red) Treg populations. For comparison purposes, values were normalized to the MFI of
naı ¨ve, control CD4
+ T cells (green); i.e. relative MFI values are shown. Values are +/2 SEM, * (p,0.05), ** (p,0.01) comparing MFI of Helios
+ versus
Helios
2 Treg. Data shown are representative of 3 independent experiments, n=3/group. D) In vitro induced Treg: Top row: Expression of indicated
cell surface molecules on in vitro induced CD4
+ FoxP3
+ Helios
+ Treg (blue) overlaid with expression on naı ¨ve CD4 T cells (green). Bottom row:
Expression on in vitro induced CD4
+ FoxP3
+ Helios
2 Treg (red), overlaid with expression on naı ¨ve CD4
+ cells. Percentages given indicate the
percentage of Treg that are positive for expression of the surface marker compared to control cells. E) Mean Fluorescence Intensity (MFI) values for
each cell surface protein in the in vitro induced Helios
+ (blue) and Helios
2 (red) Treg populations. For comparison purposes, values were normalized
to the MFI of naı ¨ve, control CD4
+ T cells (green); i.e. relative MFI values are shown. Values are +/2 SEM, * (p,0.05), ** (p,0.01), *** (p,0.001)
comparing MFI of Helios
+ versus Helios
2 in vitro induced Treg. Data shown are representative of 3 independent experiments, n=3/group.
doi:10.1371/journal.pone.0034547.g002
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e34547Figure 3. Enrichment of Helios
+ Treg by sorting on CD103 and GITR. CD4
+ enriched cells were FACS sorted by gating on CD4
+ CD25
+ cells,
then sorted into three populations based on relative CD103 and GITR staining levels. Data shown are representative of 2 independent experiments,
n=5.A) Pre and Post sort analysis: Expression of FoxP3 and Helios is shown in both bulk CD4
+CD25
+ cells and sorted cells after intracellular staining.
B) qPCR analysis: mRNA was extracted from the FACS sorted populations and reverse transcribed into cDNA. Expression of each mRNA of interest was
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population. To test this hypothesis, we first directly compared the
suppressive capacity of Helios enriched (GITR
+, CD103
+) Treg to
CD4+ CD25+ bulk Treg.(Figure 5A–B). As expected, at most of the
suppressor to effector ratios examined, the CD4
+CD25
+ bulk Treg
population showed a titratable suppression phenotype. How-
ever, the Helios/FoxP3 enriched CD4
+CD25
+CD103
+GITR
+
Treg population demonstrated significantly increased sup-
pressive capabilities at most ratios examined. Furthermore, the
CD4
+CD25
+CD103
+GITR
+ Tregs still showed moderate suppres-
sive function even at a 1:25 ratio (Figure 5A). In order to further
examine the differences in the suppressive capabilities of these
subpopulations, we assayed the three populations shown in
Figure 3A, sorting CD4
+CD25
+ bulk Treg by GITR and CD103.
As show in Figure 5C–D, the CD4
+CD25
+CD103
+GITR
+ Treg
displayed significantly increased suppressive ability over the
CD4
+CD25
+CD103
2GITR
low population at all ratios assayed.
Additionally,theCD4
+CD25
+CD103
+GITR
+Tregsshowedasmall
increase insuppressive ability over the CD4
+CD25
+CD103
2GITR
+
Tregs. These differences in the suppressive capacity of the sorted
Treg populations could be due to increases in the number of cells in
each population expressing FoxP3, Helios, or both. To examine this
question, we compared the percent suppression observed to the
number of FoxP3
+ singly positive (Figure 5E) or FoxP3
+Helios
+
doubly positive (Figure 5F) Tregs in culture (based on post sort
stainingpercentages).Weweresurprisedtofindverylittlecorrelation
(R
2=0.40) between the number of FoxP3
+ Tregs in culture and
percentage suppression (Figure 5E). However, percentage suppres-
sion correlated strongly with the number of FoxP3
+,H e l i o s
+ cells
(R
2=0.89, Figure 5F). Taken together, these data show that several
suppressor populations exist within the bulk CD4
+CD25
+ Treg
population, and that enriching for FoxP3
+Helios
+ Tregs results in an
increased in vitro suppressive capability.
Discussion
Microarray data from several groups [11–13], including our
own [14], showed increased expression of the Ikaros family
transcription factor Helios in regulatory T cells (Treg). Recently,
Thorton et al. [15] utilized a new monoclonal antibody to confirm
these observations at the protein level. This group further
suggested that Helios expression might serve to distinguish natural
(thymic-derived) from peripherally derived Treg, a finding
consistent with our data as well [16]. However, the notion that
Helios could distinguish between those two populations was
subsequently challenged by data showing Helios expression in
TCR transgenic cells induced toward a Treg phenotype in vitro.
Here we extend those more recent data, showing that in vitro
stimulation of naı ¨ve CD4 T cells in the presence of IL-2 and TGF-
b can lead to the development of both Helios
+ and Helios
2
FoxP3
+ Treg.
The function, if any, of Helios in Treg remains relatively
unknown. Indeed, either global Helios knockout [18] or CD4-
targeted Helios knockout [15] mice showed no overt deficiency in
Treg number or function. Our efforts to over-express Helios in
naı ¨ve CD4 cells have been, to date, thwarted by the observation
that successful expression seems to induce apoptosis [16]. We thus
set out to study the Helios
+ population of Treg by elucidating a
set of cell surface markers that could enrich CD4
+ CD25
+ cells
for a Helios-expressing population. Interestingly, we found that
expression of the glucocorticoid-induced TNF receptor (GITR), a
well-accepted Treg molecule [23], correlated with Helios expres-
sion in unstimulated splenic Treg. These data represented our first
data suggesting that Helios
+ Treg might represent an activated,
functional population. CD103, an a/b integrin associated with
gut-homing of lymphocytes [24], and preferentially expressed on
tumor-infiltrating Treg [22] was also relatively up-regulated on
Helios
+ versus Helios
2 Treg, again suggesting the potential for an
increased functional capacity [25,26]. These data are consistent
with a recent large-scale microarray analysis of Treg subtypes,
which also showed that Helios message correlates with CD103
expression [27].
By sorting unstimulated Treg from the spleens of unmanipu-
lated wild-type mice on CD4, CD25, GITR and CD103, we were
able to isolate a FoxP3
+ Treg population relatively enriched for
Helios expression. Our results must be tempered by the notion
that this was a relative (2 to 3) fold over-expression as compared to
GITR
low CD103
2 Treg, and that the isolation of a pure Helios
+
population will most likely require the generation of an
appropriate reporter strain of mice. Nevertheless, qPCR studies
showed a relative up-regulation of TGF-b message in Helios-
enriched Treg, providing a second indication that Helios
expression in Treg might correlate with suppressive function.
We next turned to a tumor model and found that Treg in the
tumor-infiltrating population were dramatically enriched for
Helios
+ cells. BrdU labeling studies showed that Helios
+ Treg
were proliferating in vivo to a greater exent than were Helios
2
Treg. Unfortunately, our efforts to enrich Helios
+ Treg from the
tumor bed were complicated by the finding that both Helios
+ and
Helios
2 Treg expressed similar levels of CD103 and GITR at this
location. While disappointing from an experimental standpoint,
these data are in excellent agreement with recent studies showing
that CD103 marks Treg in a tumor bed [22], and once again the
support the possibility that Helios-enriched, CD103
+ GITR
+ Treg
might represent a population with a relatively enhanced
suppressive capacity.
Using an in vitro suppression assay, we confirmed this hypothesis,
finding that CD103
+ GITR
+ CD4
+ CD25
+ (Helios-enriched) Treg
mediated a greater degree of suppression than CD4
+ CD25
+ Treg,
or GITR
low CD103
2 Treg. It has been previously shown that
CD103
+ Treg are more potent suppressors than CD103
2 Treg
[25,28,23], and our data suggests that this difference may correlate
with Helios expression. Interestingly, the degree of suppression in
any of our Treg assays was closely proportional to the absolute
number of Helios
+ cells admixed, providing reasonable support for
the notion that Helios may be a marker of Treg with functional,
suppressive capacity. Our conclusions, however, must be inter-
preted in the light of recent data, from two separate groups,
showing that Helios knockout did not affect Treg number or
function [15–18]. One interpretation of these findings is that
Helios expression in Treg is a non-essential correlate of CD103
and GITR expression, and is thus not at all necessary for Treg
activity in vivo. Another possibility is that multiple Ikaros family
members operate in concert to modulate Treg function, as has
been observed for Ikaros and Helios in determining SHIP
expression in B cells [29]. Despite these caveats, our data support
the notion that Helios expression, while likely not absolutely
required for Treg function, correlates with the functional capacity
of Treg in vitro.
quantified as compared to an internal control18S rRNA. Data shown are relative expression as compared to a CD4
+ CD25
2 reference sample. Mean
values are plotted +/2 SEM.
doi:10.1371/journal.pone.0034547.g003
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e34547Figure 4. Helios+ Treg proliferate within tumors. Lymphocytes were isolated from the spleens, irrelevant lymph nodes, tumor draining lymph
nodes, and tumor masses of mice bearing 4T1 tumors 10 days post implantation. Data shown are representative of 2 independent experiments, n=5/
group. A) Intracellular staining: lymphocytes were obtained from the indicated tissues and stained for CD4, followed by intracellular staining for
Helios, FoxP3, and BrdU. B) Quantification of Helios
+ versus Helios
2 Treg. Absolute number of Helios
+ Treg divided by absolute number of Helios
2
Treg in given tissues, i.e. numerical ration of Helios
+ versus Helios
2 Treg. Data plotted are +/2 SEM. C) Brdu incorporation into Helios
+ (solid line)
versus Helios
2 (shaded histogram) Treg. Percentages denote the percentage of Treg from each population that are Brdu
+. D) Relative proliferation of
Helios
+ Treg versus Helios
2 Treg. MFI of BrdU staining in Helios
+ was divided by MFI of BrdU staining in Helios
2 Treg in given tissues. Data plotted are
+/2 SEM.
doi:10.1371/journal.pone.0034547.g004
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e34547Figure 5. Increased suppressive function of Helios-enriched Treg populations. Standard in vitro suppression assays were performed using
either bulk CD4
+ CD25
+ Treg, CD4
+CD25
+GITR
+CD103
+ Treg, CD4
+CD25
+GITR
low CD103
2 Treg or CD4
+CD25
+CD103
2GITR
+ Treg. Data shown are
representative of 2 independent experiments, n=4. A) Relative proliferation of effectors by H
3 incorporation. B) Analysis of Treg function at 1:10
suppressor:effector ratio. C) Relative proliferation of effectors by H
3 incorporation. D) Analysis of Treg fuction at 1:10 suppressor:effector ratio. E)
Percent suppression (as compared to no suppressor control) versus the absolute number of FoxP3
+ Treg admixed. F) Percent suppression (as
compared to no suppressor control) versus the absolute number of FoxP3
+Helios
+ Treg admixed.
doi:10.1371/journal.pone.0034547.g005
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Figure S1 Increasing concentrations of a-CD3 and/or a-
CD28 do not result in significant Helios induction in
vitro. A) Experiments were performed in the same fashion as in
Figure 1B.Cells were stimulated with either 0, 5, 10, or 25 mg/mL
of plate bound a-CD3 and 1.25 mg/mL of soluble a-CD28. B)
Cells were stimulated with either 0, 5, 10, or 25 mg/mL of soluble
a-CD28 and 1.25 mg/mL of plate bound a-CD3. C) Cells were
stimulated with 0, 5, 10, or 25 mg/mL of both plate bound a-CD3
and soluble a-CD28.
(TIF)
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